封面
市场调查报告书
商品编码
1922541

日本家庭输液治疗市场报告:按产品、应用和地区划分(2026-2034年)

Japan Home Infusion Therapy Market Report by Product, Application, and Region 2026-2034

出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年,日本家庭输液治疗市场规模为28.622亿美元。展望未来,IMARC集团预测,到2034年,该市场规模将达到49.476亿美元,2026年至2034年的复合年增长率(CAGR)为6.27%。慢性病盛行率的上升、居家医疗需求的成长以及产品供应的不断进步是推动市场成长的主要因素。

居家输液治疗(HOMET)是一种特殊的医疗程序,它利用包括输液帮浦、导管和管瓶的各种设备,在患者舒适的家中透过静脉注射输注药物、液体和营养物质,例如抗病毒药物和免疫球蛋白。对于需要长期或频繁静脉输液治疗的感染疾病、癌症或慢性疾病(例如多发性硬化症 (MS) 和类风湿性关节炎)患者,建议采用此疗法。居家输液治疗为患者带来舒适和便利,提高他们的生活质量,并降低医院感染的风险。它也能让病人在接受所需照护的同时,保持治疗的独立性和自主性,从而增强他们的自主权。居家输液治疗对多种治疗尤其有效,包括化疗、补液、经肠营养正性肌力药物、抗感染剂、营养支持和疼痛管理。它被广泛用于治疗糖尿病、各种胃肠道疾病和肿瘤。

日本家庭输液治疗市场的发展趋势:

由于癌症、骨关节炎、人类免疫力缺乏病毒(HIV)和糖尿病等慢性疾病的日益普遍,日本的家庭输液治疗市场正经历显着增长。老年人口的成长,尤其是那些容易罹患危及生命的疾病、需要定期医疗照护(特别是输液治疗)的老年人,也大大促进了市场成长。此外,政府的各项措施、优惠的报销政策以及长期住院费用的不断上涨,都促使患者选择家庭输液治疗,进一步推动了市场扩张。居家医疗服务的便利性和成本效益日益受到青睐,加之医院资源日益紧张,这些因素也进一步促进了成长要素。由于长期接触受污染的医疗设备、床单和飞沫,医院感染(HAI)的增加也推动了市场扩张。对需要特殊给药方式的特殊药物的广泛需求,也是推动市场成长的重要因素。此外,轻巧、携带式、易于使用的输液泵的开发,以及先进的滴注系统,能够对输液治疗进行精确和即时的监测,这些创新技术进步预计将在预测期内推动市场成长。

本报告解答的关键问题

  • 日本家庭输液治疗市场目前发展状况如何?未来几年又将如何发展?
  • 新冠疫情对日本家庭输液治疗市场产生了哪些影响?
  • 日本家庭输液治疗市场的产品组成是什么?
  • 日本家庭输液治疗市场按应用领域分類的市场区隔如何?
  • 日本家庭输液治疗市场价值链的不同阶段有哪些?
  • 日本家庭输液治疗的主要驱动因素和挑战是什么?
  • 日本家庭输液治疗市场的结构是怎么样的?主要参与者有哪些?
  • 日本家庭输液治疗市场竞争有多激烈?

目录

第一章:序言

第二章:调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章:日本家庭输液治疗市场-引言

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本家庭输液治疗市场概览

  • 过去和当前的市场趋势(2020-2025)
  • 市场预测(2026-2034)

第六章 日本家庭输液治疗市场-依产品细分

  • 点滴帮浦
  • 静脉输液装置
  • 静脉插管
  • 无针头连接器

第七章 日本家庭输液治疗市场-依应用领域细分

  • 抗感染剂
  • 内分泌学
  • 水疗法
  • 化疗
  • 经肠营养
  • 肠外营养
  • 特种药品
  • 其他的

第八章:日本家庭输液治疗市场:依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第九章:日本家庭输液治疗市场:竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十章主要企业概况

第十一章:日本家庭输液治疗市场:产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十二章附录

简介目录
Product Code: SR112026A19967

Japan home infusion therapy market size reached USD 2,862.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 4,947.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.27% during 2026-2034 . The growing incidence of chronic illnesses, the rising inclination towards home healthcare, and continuous advancements in product offerings are among the primary factors propelling the market growth.

Access the full market insights report Request Sample

Home infusion therapy is a specialized medical treatment that involves delivering medications, such as antivirals or immune globulin, fluids, or nutrition intravenously to patients in the comfort of their homes, utilizing various equipment like pumps, catheters, and vials. This form of therapy is recommended for individuals dealing with infections, cancer, or chronic conditions like multiple sclerosis (MS) or rheumatoid arthritis that necessitate long-term or frequent infusion treatment. Home infusion therapy provides a sense of comfort and convenience, enhances the overall quality of life, and diminishes the risk of hospital-acquired infections. Moreover, it empowers patients by allowing them to maintain a sense of independence and control over their treatment while still receiving essential medical care. Home infusion therapy is particularly effective in diverse treatments, including chemotherapy, hydration, enteral, inotropic, anti-infective, nutritional, and pain management therapies, commonly employed for conditions such as diabetes and various gastrointestinal and oncological disorders.

JAPAN HOME INFUSION THERAPY MARKET TRENDS:

The Japan home infusion therapy market is witnessing substantial growth, driven by an increase in the prevalence of chronic diseases like cancer, osteoarthritis, human immunodeficiency viruses (HIV), and diabetes. The expanding geriatric population, more susceptible to life-threatening illnesses requiring regular medical attention, particularly infusion therapy, is also contributing significantly to market growth. Besides this, government initiatives, favorable reimbursement policies, and the rising costs associated with prolonged hospital stays are motivating patients to opt for home infusion therapy, further fueling market expansion. Additionally, the growing preference for home healthcare services due to their convenience and cost-effectiveness, coupled with the increasing strain on hospital resources, is acting as another significant growth-inducing factor. Apart from this, the rise in hospital-acquired infections (HAIs) due to prolonged exposure to contaminated equipment, bed linens, and air droplets is amplifying the market's expansion. The widespread demand for specialty drugs, necessitating specialized administration, adds another layer of growth to the market. Furthermore, innovative technological advancements, such as the development of lightweight, portable, and user-friendly infusion pumps equipped with advanced drip systems for precise and real-time monitoring of IV treatments, are anticipated to fuel the market growth over the forecasted period.

JAPAN HOME INFUSION THERAPY MARKET SEGMENTATION:

Product Insights:

  • To get detailed segment analysis of this market Request Sample
  • Infusion Pumps Elastomeric Electromechanical Gravity Others
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors
  • Infusion Pumps Elastomeric Electromechanical Gravity Others
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

Application Insights:

  • Anti-Infective
  • Endocrinology Diabetes Others
  • Diabetes
  • Others
  • Hydration Therapy Athletes Others
  • Athletes
  • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others
  • Anti-Infective
  • Endocrinology Diabetes Others
  • Diabetes
  • Others
  • Diabetes
  • Others
  • Diabetes
  • Others
  • Hydration Therapy Athletes Others
  • Athletes
  • Others
  • Athletes
  • Others
  • Athletes
  • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan home infusion therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan home infusion therapy market?
  • What is the breakup of the Japan home infusion therapy market on the basis of product?
  • What is the breakup of the Japan home infusion therapy market on the basis of application?
  • What are the various stages in the value chain of the Japan home infusion therapy market?
  • What are the key driving factors and challenges in the Japan home infusion therapy?
  • What is the structure of the Japan home infusion therapy market and who are the key players?
  • What is the degree of competition in the Japan home infusion therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Home Infusion Therapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Home Infusion Therapy Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Home Infusion Therapy Market - Breakup by Product

  • 6.1 Infusion Pumps
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Elastomeric
      • 6.1.3.2 Electromechanical
      • 6.1.3.3 Gravity
      • 6.1.3.4 Others
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Intravenous Sets
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 IV Cannulas
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Needleless Connectors
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)

7 Japan Home Infusion Therapy Market - Breakup by Application

  • 7.1 Anti-Infective
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Endocrinology
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Diabetes
      • 7.2.3.2 Others
    • 7.2.4 Market Forecast (2026-2034)
  • 7.3 Hydration Therapy
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Segmentation
      • 7.3.3.1 Athletes
      • 7.3.3.2 Others
    • 7.3.4 Market Forecast (2026-2034)
  • 7.4 Chemotherapy
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Enteral Nutrition
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Parenteral Nutrition
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Specialty Pharmaceuticals
    • 7.7.1 Overview
    • 7.7.2 Historical and Current Market Trends (2020-2025)
    • 7.7.3 Market Forecast (2026-2034)
  • 7.8 Others
    • 7.8.1 Historical and Current Market Trends (2020-2025)
    • 7.8.2 Market Forecast (2026-2034)

8 Japan Home Infusion Therapy Market - Breakup by Region

  • 8.1 Kanto Region
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Breakup by Product
    • 8.1.4 Market Breakup by Application
    • 8.1.5 Key Players
    • 8.1.6 Market Forecast (2026-2034)
  • 8.2 Kansai/Kinki Region
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Breakup by Product
    • 8.2.4 Market Breakup by Application
    • 8.2.5 Key Players
    • 8.2.6 Market Forecast (2026-2034)
  • 8.3 Central/ Chubu Region
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Breakup by Product
    • 8.3.4 Market Breakup by Application
    • 8.3.5 Key Players
    • 8.3.6 Market Forecast (2026-2034)
  • 8.4 Kyushu-Okinawa Region
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Breakup by Product
    • 8.4.4 Market Breakup by Application
    • 8.4.5 Key Players
    • 8.4.6 Market Forecast (2026-2034)
  • 8.5 Tohoku Region
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Breakup by Product
    • 8.5.4 Market Breakup by Application
    • 8.5.5 Key Players
    • 8.5.6 Market Forecast (2026-2034)
  • 8.6 Chugoku Region
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2020-2025)
    • 8.6.3 Market Breakup by Product
    • 8.6.4 Market Breakup by Application
    • 8.6.5 Key Players
    • 8.6.6 Market Forecast (2026-2034)
  • 8.7 Hokkaido Region
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2020-2025)
    • 8.7.3 Market Breakup by Product
    • 8.7.4 Market Breakup by Application
    • 8.7.5 Key Players
    • 8.7.6 Market Forecast (2026-2034)
  • 8.8 Shikoku Region
    • 8.8.1 Overview
    • 8.8.2 Historical and Current Market Trends (2020-2025)
    • 8.8.3 Market Breakup by Product
    • 8.8.4 Market Breakup by Application
    • 8.8.5 Key Players
    • 8.8.6 Market Forecast (2026-2034)

9 Japan Home Infusion Therapy Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Home Infusion Therapy Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix